PUBLISHED ARTICLES & STUDIES

Biography


PUBLISHED ARTICLES & STUDIES

  1. Futterweit W, Schookhoff, HB: Relative Efficiency of Fingercot Specimens and Stool Examinations on Screening for Schistosoma Mansoni and other Parasitic Infections, New Engl J Med, 263:1018-1020, 1960.
  2. Futterweit W: Serum Alkaline Phosphatase Activity in Infectious Mononucleosis. A Clinical Study of Fifty-five Cases, Arch Int Med 108:253-268, 1961.
  3. Soffer LJ, Futterweit W, Salvaneschi, J: A Gonadotropin-Inhibiting Substance in the Urine of Normal Young Children, J. Clin Endocrinol Metab 21:1267-1271, 1961.
  4. Futterweit W, Chapman ML, Salvaneschi JP, Moloshok, RB: Multiple Congenital Defects in a Twelve-Year-Old Boy with Cryptorchidism- “Male Turner’s Syndrome”, Metabolism, 10:1074-1084,1961.
  5. Futterweit W, Krieger DT, Gabrilove JL: Adrenal Cortical Function Studies in Cushing’s Syndrome Due to Non-tumorous Adrenocortical Hyperfunction Treated with Pituitary Irradiation, J Clin Endocrinol. Metab 22:364-367, 1962.
  6. Soffer LJ, Salvaneschi, J, Futterweit, W: A Gonadotropin-Inhibiting Substance in the Urine of Normal Subjects, J. Clin. Endocrinol Metab 22:532-534, 1962.
  7. Futterweit W, Allen L, Moser M: Pheochromocytoma with Radioactive Iodine Uptake and Electrocardiographic Abnormalities: Case Report with a Review of Thyroid-Adrenal Medullary Interrelationships, Metabolism 11:589-599, 1962.
  8. Dorfman RI, Forchielli E., Ishii S, Futterweit W: Evaluation of Androgens and Estrogens in Normal and Abnormal States, Third Annual Meeting of the Mexican Society of Nutrition and Endocrinology, San Jose Purua, Mexico, Nov. 23-24, 1962, pp. 141-150.
  9. Futterweit W, McNiven NL, Dorfman RI: Gas-Chromatographic Identification of Progesterone in Human Pregnancy Plasma, Biochem & Biophys Acta 71:474-476, 1963.
  10. Futterweit W, McNiven NL, Narcus L, Lantos C, Drosdowsky M, Dorfman RI: Gas-Chromatographic Determination of Testosterone in Human Urine, Steroids 1:628- 642, 1963.
  11. Futterweit W, Margolis SA, Soffer LJ, Dorfman RI: Effect of Urinary Gonadotropins on the Mouse Uterine Response to Various Gonadotropins, Endocrinol, 72:903-907, 1963.
  12. Futterweit W: Section on Endocrinology and Metabolic Diseases, Internal Medicine Journal Review, 181-213, Medical Examination Publishing Co., Flushing, NY, 1963.
  13. Futterweit W, Seckler SG: Recurrent Epigastric Pains Simulating Peptic Ulcer in Postpartum Pituitary Necrosis, Amer J Digest Dis 9:434-438, 1964.
  14. Futterweit W, McNiven NL, Guerra-Garcia R, Gibree N, Drosdowsky M, Siegel GL, Soffer LJ, Rosenthal IM, Dorfman RI: Testosterone in Human Urine, Steroids, 4:137-145, 1964.
  15. Futterweit W: Section on Endocrinology .and Metabolic Diseases, Internal Medicine Specialty Board Review 62-93, 1964. Medical Examination Publishing Co., Flushing, New York .
  16. Futterweit W, Freeman R, Siegel GL, Griboff SI, Dorfman RI, Soffer, LJ: Testosterone in Human Urine, Paper presented at the Workshop on Gas-Chromatography of Steroids, Airlie House, Warrenton, Va., February 25-27,1965.
  17. Futterweit W, Freeman R, Siegel GL, Griboff SI, Dorfman RI, Soffer LJ: Clinical Applications of a Gas-Chromatographic Method for the Combined Determination of Testosterone and Epitestosterone Glucuronide in Urine, J Clin Endocrinol Metab 25:1451-1456, 1965.
  18. Futterweit W, Schwartz MJ, Mirsky S: Blepharoptosis in Diabetes Mellitus, Abstract. Twenty-fifth Annual Meeting of the American Diabetes Association, June 19-20, 1965, Hotel Roosevelt, New York, New York.
  19. Futterweit W, Schwartz MJ, Mirsky S: Blepharoptosis in Diabetes Mellitus, J Clin Endocrinol Metab 25:1280-1283, 1965.
  20. Griboff SI, Futterweit W: The Treatment of Alopecia with Dichlorisone and 16a-methyl-dichlorisone Compounds, Abstract of Paper presented at the Second International Congress on Hormonal Steroids, Milan, Italy, May 23-28, 1966.
  21. Futterweit W: Section on Endocrinology and Metabolic Diseases, Internal Medicine Specialty Board Review, 1966, Medical Examination Publishing Co., Flushing, New York.
  22. Futterweit W, Siegel GL, Freeman R, Griboff SI, Drosdowsky M, Gibree N, Dorfman RI, Soffer LJ: Gas Chromatographic Method for the Determination of Testosterone in Human Urine, -In Gas Chromatography of Steroids in Biological Fluids (Proc. Workshop on GLC of Steroids) Feb. 25-27, 1965 Airlie House, Warrenton, VA, Plenum Press, pp 19-22.
  23. Schwartz MJ, Mirsky S, Futterweit W: The Effect of Probenecid on Serum Lipids: A Study of Diabetes and Non-Diabetics Without Gout, J Mt Sinai Hosp, 34:96-102,1967.
  24. Griboff SI, Futterweit W: Effects of New 9,11-Dihalogenated Corticosteroids in Various Types of Alopecia. Part I. Clinical Studies in Thirty-two Patients, J Mt. Sinai Hosp 34:121-129,1967.
  25. Griboff SI, Futterweit W: Effects of New 9,11-Dihalogenated Corticosteroids in Various Types of Alopecia. Part 11. Pituitary-Adrenal Responsiveness in Patients Treated with 16α-methyl-dichlorisone alcohol, J Mt Sinai Hosp 34:130-134,1967.
  26. Futterweit W: Spermatozoa in Seminal Fluid of a Patient with Klinefelter’s Syndrome, Fertil Steril, 18:492-496, 1967.
  27. Futterweit W, Freeman R, Siegel GL, Griboff SI: Measurement of Urinary Testosterone and Epitestosterone Glucuronide as a Test of Gonadal Reserve, Fertil Steril 18:659-665, 1967.
  28. Futterweit W, Sobrero AJ: Large Doses of Chorionic Gonadotropin in Males with Normogonadotropic Oligospermia, Paper presented at the 24th Annual Meeting of the American Fertility Society, San Francisco, CA., March 28th, 1968.
  29. Griboff SI, Futterweit W: Buccal Androsterone Therapy of Hirsutism: A Preliminary Report. J Mount Sinai Hosp 35:179-183, 1968.
  30. Futterweit W: Section on Endocrinology and Metabolic Diseases, Internal Medicine Specialty Board Review, 1968. Medical Examination Publishing Co., Flushing, N.Y.
  31. Futterweit W, Sobrero AJ: Treatment of Normogonadotropic Oligospermia with Large Doses of Chorionic Gonadotropin, Fertil Steril 19:971-976,1968.
  32. Futterweit W, Eng Y, Griboff SI: Gonadal Reserve Test in Male Hypogonadism. Paper presented at the North American Conference on Fertility and Sterility, January 11, 1970, Dorado, Puerto Rico.
  33. Futterweit W, Griboff S, Eng Y: Gonadal Reserve Test in Male Hypogonadism. Fertil Steril 21:574:580,1970.
  34. Sobrero AJ, Futterweit W: Human Chorionic Gonadotropin in the Treatment of Male Infertility. Paper presented at the North American Conference on Fertility and Sterility, Jan. 11, 1970, Dorado, P.R.
  35. Futterweit W, Goodsell CH: Galactorrhea in Primary Hypothyroidism: Report of Two Cases and Review of the Literature, Mt Sinai J Med. 37:584-589,1970.
  36. Futterweit W.: Section on Endocrinology and Metabolic Diseases, Internal Medicine Specialty Board Review, 3rd Edition, Medical Examination Publishing Co., Flushing, N.Y., 1970
  37. Kolodny HD, Kim S, Sherman L: Futterweit W. Benjamin F: Anorchia. A Variety of the "Empty Scrotum". JAMA 216:479-482,1971.
  38. Futterweit W, Eng Y, Griboff SI: Gas-Chromatographic Determination of Urinary Testosterone and Epitestosterone Glucuronide, Mt Sinai J Med 38:281-283, 1971.
  39. Futterweit W: Section on Endocrinology and Metabolic Diseases, Internal Medicine Specialty Board Review, 4th Edition, Medical Examination Publishing Co., Flushing, N.Y., 1972.
  40. Merker E, Futterweit W: Postpartum Amenorrhea, Diabetes Insipidus and Galactorrhea. Report of a Case and Review of the Literature. Am J Med 56:554-558,1974.
  41. Futterweit W: Prolactin Producing Pituitary Adenomas and Polycystic Ovarian Disease. Abstract #746, Endocrine Society, 60th Annual Meeting, Miami, June 1978.
  42. Futterweit W, Schwartz AE: Hyperparathyroidism with Aberrant Hyperplastic Parathyroid Located within Thyroid Adenoma, Mt Sinai J Med 46:61-62,1979.
  43. Futterweit W, Krieger DT: Pituitary Tumors Associated with Hyperprolactinemia and Polycystic Ovarian Disease, Fertil Steril 31:608-613, 1979.
  44. Futterweit W: Endocrine Management of Transsexual. Hormonal Profiles of Serum Prolactin, Testosterone and Estradiol. NY St J Med 80:1260-1264,1980.
  45. Teperman L, Futterweit W, Zappula R, Malis LI: Oral Contraceptive History as a Risk Indicator in Patients with Pituitary Tumors with Hyperprolactinemia: A Case Comparison Study of Twenty Patients. Neurosurgery 7: 571-573,1980.
  46. Bergman D, Futterweit W, Segal R, Sirota D: Increased Oestradiol in Diazepam Related Gynaecomastia. Lancet 2: 1225-1226,1981.
  47. Avruskin TW, Davies TE, Futterweit W, Pepper GM: The Neglected Male. Fertil Steril 37:282,1982.
  48. Futterweit W: Galactorrhea, Amenorrhea, Hyperprolactinemia and Pseudotumor Cerebri in a Patient with Primary Empty Sella Syndrome: Case Report with Review of the Literature. Mt Sinai J Med 49:514-518,1982.
  49. Ihlenfeld CL, Oppenheim G, Ellis A, Schaefer L, Lehfeldt IT, Mency J, Pauly I, Far J, Futterweit W, Green R, Richards R, Jorgensen C, Allen V, Wheeler CC. Memorial for Harry Benjamin. Arch Sex Behav 17: 1-31,1982.
  50. Weisen M, Futterweit W: Normal Plasma Gonadotropin Response to Gonadotropin Releasing Hormone (GnRH) following Diethylstilbestrol Priming in Transsexual Women. J Clin Endocrinol Metab 57:197-199,1983.
  51. Futterweit W: Pituitary Tumors and Polycystic Ovarian Disease. Obstet Gynecol 62:S74-79,1983.
  52. Futterweit W, Scher J, Nunez A, Strauss L, Rayfield EJ: A Case of Bilateral Dermoid Cysts, Insulin Resistance and Polycystic Ovarian Disease: The Association of Ovarian Tumors with Polycystic Ovaries with a Review of the Literature. Mt Sinai J Med 50:251-255,1983.
  53. Futterweit W: hCG Treatment in Oligoasthenospermia. Fertil Steril 40:703, 1983.
  54. Futterweit W: Viewpoints: Is There a Male Climacteric? Med Aspects Human Sexuality 18:147-148,1984.
  55. Futterweit W: The Adrenal Gland in Male Infertility, In, Current Therapy of Infertility 1984-1985, Eds. Garcia CR, Mastroianni L Jr, Amelar RD, Dubin L: New York, B.C. Decker Inc, pp 156-159.
  56. Mechanick JI, Futterweit W: Hypothesis: Aberrant. Puberty and the Stein-Leventhal Syndrome. Internatl J Fert:29:35-38,1984.
  57. Futterweit W: Polycystic Ovarian Disease. Springer-Verlag, New York, 1984.
  58. Futterweit W, Gabrilove JL, Smith H: Testicular Steroidogenic Response to Human Chorionic Gonadotropin of Fifteen Male Transsexuals on Chronic Estrogen Treatment. Metabolism 33:936-942,1984.
  59. Futterweit W, Smith H Jr, Holt, JE: Dissociation of serum prolactin response to sequential thyrotropin- releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome. Fertil Steril 42:573-578,1984.
  60. Teekhasaenee CT, Ritch R, Futterweit W: Congenital ectropion uveae in a patient with Prader-Willi syndrome. (Abstract). Presented at the International Ophthalmic Genetics Society, Atlanta, GA., Nov 10,1984.
  61. Segal RL, Cobin RH, Futterweit W, Fiedler RP, Sirota DK: Thyroid Nodules in the Irradiated Patient - An Indication for Total Thyroidectomy. J Sur Oncol 28:126-130,1985.
  62. Yeh HC, Futterweit W: Ultrasonographic Features of Polycystic Ovarian Disease and Their Correlation with Hormonal Abnormalities. Presented at the Radiological Society of No. America, Chicago, Ill. Nov. 17-22,1985. Paper # 123.
  63. Futterweit W, Deligdisch L, Oppenheim G: Female to male transsexualism and polycystic ovarian disease (PCOD): Is There an Association? Paper presented at Ninth International Symposium on Gender Dysphoria, Minneapolis, MN, Sept.12-15,1985.
  64. Cobin RH, Futterweit W, Fiedler RP, Thornton JC: Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness. Fertil Steril 44:224-226,1985.
  65. Futterweit W, Deligdisch L: Histopathological Effects of Exogenously Administered Testosterone in 19 Female to Male Transsexuals. J Clin Endocrinol Metab 62:16-21,1986.
  66. Furth PA, Futterweit W, Gorlin R: Case Report: Refractory Biventricular Heart Failure in Secondary Hemochromatosis. Am J Med Sciences 290:209-212, 1986.
  67. Futterweit W, Weiss RA, Fagerstrom RM: Endocrine Evaluation of Forty Female-to-Male Transsexuals: Increased Frequency of Polycystic Ovarian Disease in Female Transsexualism. Arch Sex Behav 15:67-76,1986.
  68. Dunaif A, Futterweit W, Dobrjansky A, Laumas V: The Effects of Continuous Androgen Secretion on the Hypothalamic- Pituitary Axis in Woman: Evidence from Transsexuals (TS). Endocrine Society 68th Annual Meeting, Anaheim, Cal. June 25-27, 1986.
  69. Futterweit W, Yeh HC, Thornton JC: Lack of Correlation of Ovarian Size with Multiple Endocrine Variables in 45 Patients with Polycystic Ovarian Disease. The American Fertility Society 42nd Annual Meeting, Toronto, Canada, Sept. 27 - October 2, 1986. Abstract #92.
  70. Wachtel S, Green R, Simon NG, Reichart A, Cahill L, Hall J, Nakamura D, Wachtel G, Futterweit W, Biber SH: On the expression of H-Y antigen in transsexuals. Arch Sex Behav 15:51-68,1986.
  71. Futterweit W, Yeh HC, Mechanick JI: (letter) Multifollicular ovaries in weight-loss-related amenorrhoea. Lancet 1:796,1986.
  72. Mechanick Jl, Futterweit W: The Aberrant Puberty Hypothesis of Polycystic Ovarian Disease: A Review. Mt Sinai J Med 53:310-314,1986.
  73. Futterweit W, Ritch R, Teekhasaenee C, Nelson ES: Coexistence of Prader-Willi Syndrome, Congenital Ectropion Uveae with Glaucoma, and Factor XI Deficiency. JAMA 255:3280-3282,1986.
  74. Deligdisch L, Futterweit W: Histopathological Effects of Testosterone in Female to Male Transsexuals. XVIth Congress of the International Academy of Pathology, Vienna, Austria, August 31-September 5, 1986.
  75. Futterweit W, Deligdisch L: (letter) Effects of Androgens on the Ovary. Fertil Steril 46:343,1986.
  76. Yeh HC, Futterweit W, Thornton JC: Polycystic Ovarian Disease: US Features in 104 Patients. Radiology 163:111-116,1987.
  77. Futterweit W, Yeh HC, Kingsley P: The Prevalence of Hyperandrogenism in 109 Consecutive Women Presenting with Diffuse Alopecia: Endocrine Society, 69th Annual Meeting. Indianapolis, Indiana: June 10-12, 1987. Abstract # 771.
  78. Futterweit W, Mechanick JI: Myotonic Dystrophy Presenting as Male Infertility: A Case Report. International J Fert 32:142-144,1987.
  79. Futterweit W, Yeh IC, Thornton JC: Lack of Correlation of Ultrasonographically Determined Ovarian Size with Age, Ponderal Index, and Hormonal Factors in 45 Patients with Polycystic Ovarian Disease. International J Fert. 32:456-459,1987.
  80. Futterweit W: Hyperprolactinemia and Polycystic Ovarian Disease. In, Current Therapy of Infertility-3rd Edition. Eds: Garcia CR, Mastroianni L Jr., Amelar RD, Dubin L: New York, D.C. Decker Inc., pp 27-29,1988.
  81. Futterweit W: Adrenal Gland in Male Infertility. In, Current Therapy of Infertility-3rd Edition, Eds: Garcia CR, Mastroianni L Jr., Amelar RD, Dubin, L: New York, B.C. Decker, Inc., pp. 184-186,1988.
  82. Futterweit W: Memorial for Harry Benjamin. Arch. Sex Behavior 19: 19-20, 1988.
  83. Speiser PW, Futterweit W, Gabrilove JL, Post K: ACTH- producing pituitary tumors in adrenal steroid 21-hydroxylase deficiency. Endocrine Society, 70th Annual Meeting, New Orleans, LA, June 8-11 1988, Abstract #384.
  84. Dunaif A, Futterweit W, Lewy L, Segal K, Dobrjansky A: Profound peripheral and hepatic insulin resistance, independent of obesity, in the polycystic ovary syndrome (PCO). Endocrine Society, 70th Annual Meeting, New Orleans, LA, June 8-11, 1988, Abstract #734.
  85. Futterweit W, Yeh HC, Mechanick JI: Ultrasonographic study of ovaries of 19 women with weight-loss related hypothalamic oligo-amenorrhea. Biomed. & Pharmacother. 42:279-284,1988.
  86. Dunaif A, Futterweit W: Polycystic Ovary Syndrome (letter). New Engl J Med. 319:584, 1988.
  87. Futterweit W, Schwartz IS: Histopathology of the breasts of 12 women receiving long-term exogenous androgen therapy. Mt Sinai J Med 55:309-312, 1988.
  88. Futterweit W, Dunaif A, Yeh HC, Kingsley P: The prevalence of hyperandrogenism in 109 consecutive patients with diffuse alopecia. J Am Acad Dermatol 19:831-836,1988.
  89. Futterweit W, Mechanick JI: polycystic ovarian disease: Etiology, diagnosis, and treatment. Comp Therapy 14:12-20,1988.
  90. Yagil Y, Futterweit W, Krakoff LR, Rubin H, Weinrauch H: Cerebellar tumor causing hypertensive crisis and simulation pheochromocytoma and Cushings ‘ syndrome. Mt Sinai J Med 56:56-58,1989.
  91. Futterweit W, Halmi NS, Mechanick JI, Song SK: LH-secreting adenoma presenting with galactorrhea-amenorrhea in an 18-year old woman. Abstract # 1706. Endocrine Society, 71st Annual Meeting, Seattle, Wash, June 21-24, 1989.
  92. Dunaif A, Futterweit W, Green G, Tattersall I, Dobrjansky A: Does hyperandrogenemia sustain insulin resistance in the polycystic ovary syndrome (PCO)? Abstract #1239. Endocrine Society, 71st Annual Meeting, Seattle, Wash, June 21-24, 1989.
  93. Dunaif-A, Green G, Lewy L, Phelps R, Futterweit W, Lebwohl M: The significance of acanthosis nigricans (AN) in relationship to In Vivo insulin action and hyperandrogenism. Abstract #773, American Diabetes Association 49th Annual Meeting, Detroit, Michigan, June 3-6, 1989. (Publ. in Diabetes 38: Suppl. 2:201A, May 1989.
  94. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome: Diabetes 38:1165-1174, 1989.
  95. Dunaif A, Green G, Futterweit W, Dobrjansky A: Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab, 70:699-704,1990.
  96. Shelley D, Dobrjansky A, Futterweit W, Dunaif A: Ontogeny, mechanisms, and heterogeneity of androgen action on the hypothalamic-pituitary axis of women. Abstract # 1366, Endocrine Society; 72nd Annual Meeting, Atlanta GA, June 20-23,1990.
  97. Roman SH, El-Harazy E, Futterweit W: Absence of effect of mild and severe hyperandrogenemia on detection of thyroid autoantibodies in reproductive age women. Abstract # 304, Endocrine Society, 72nd Annual Meeting, Atlanta GA, June 20-23,1990.
  98. Futterweit W, Tarlin N, Green G, Dunaif A: Chronic high dosage androgen administration to ovulatory women does not alter adrenocortical steroidogenesis. Abstract # 925, Endocrine Society, 73rd Annual Meeting, Washington D.C., June 19-22,1991.
  99. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L: Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological and biochemical findings. J Clin Endocrinol Metab 73:590-595, 1991.
  100. Wortsman J, De Angeles S, Futterweit W, Singh KB, and Kaufmann RC: Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 36:659-661,1991.
  101. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L. Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab 1991;73:590-595.
  102. Sirota DK, Cobin RH, Futterweit W, Segal RL, Jacobs DR, Merker E: Hyperthyroidism in Patients Treated with Lithium: Report of Nine Cases. Mt Sinai J Med. 59:79-81,1992.
  103. Rushton DH, Futterweit W, Kingsley DH, Kingsley P, Norris MJ: Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia. J Soc Cosmetic Chemists 42:317-325,1991.
  104. Dunaif A, Futterweit W, Green G, Tattersall I, Dobrjansky A: Does hyperandrogenemia sustain insulin resistance (IR) in the polycystic ovary syndrome (PCO)? (Abstr). Mt. Sinai J Med 57:50,1990.
  105. Futterweit W, Halmi NS, Mechanick JI, Song SK: LH-secreting adenoma presenting with galactorrhea-amenorrhea in an 18-year old woman (Abstr). Mt. Sinai J Med 57:50,1990.
  106. Heller DS, Ranzini A, Futterweit W, Dottino P, Deligdisch L: Mullerian remnants in complete androgen insensitivity syndrome. Intl J Fert 37:283-285, 1992.
  107. Futterweit W, Green G, Tarlin N, Dunaif A: Chronic high-dosage androgen administration to ovulatory women does not alter adrenocortical steroidogenesis. Fertil Steril 58:124-128, 1992.
  108. Leiter E, Futterweit W, Brown GR: Gender reassignment: psychiatric endocrinologic, and surgical management. In, Reconstructive Urology, Eds: Webster G, Kirby R, King L, Goldwasser B. Blackwell Scientific Publications, Oxford.,Chapter 6, pp. 921-932,1993.
  109. Futterweit W: Obesity and the endocrine system. In, Obesity: New Directions in Assessment and Management. Eds: VanIttalie TB, Simopoulos AP; Co-Eds: Gullo SP, Futterweit W. The Charles Press, Philadelphia, pp 96-121,1995.
  110. Futterweit W: Pathophysiology of polycystic ovarian syndrome, In, Androgenic Disorders. Ed: Redmond GP, Raven Press, New York, pp 77-166, 1995.
  111. Schaefer,LC, Wheeler CC, Futterweit W: Gender Identity Disorders (Transsexualism) ln Section 9, Ch.23, Volume 2, of Treatments of Psychiatric Disorders, 2nd Ed., Ed: Gabbard GO, American Psych Press Inc., Washington DC, pp2015-2079, 1995.
  112. Yeh HC, Futterweit W, Gilbert P: Micronodulation- a new ultrasonographic sign in Hashimoto's thyroiditis. Abstract and exhibit at 81st Scientific Assembly and Annual Meeting, Chicago, November 26-Dec l, 1995.
  113. Yeh HC, Futterweit W, Gilbert P: Micronodulation: Ultrasonographic sign of Hashimoto's thyroiditis. J Ultrasound Med 15:813-819,1996.
  114. Phillips R, Travis A, Futterweit W, Martin A, Gharavi J, Jhang J, Lipkowitz, M: Resistance to sodium reabsorption in polycystic ovarian syndrome during a hyperinsulinemic euglycemic clamp. Endocrine Society 79th Annual Meeting, Minneapolis, MN, June 11-14,1997, (Oral Sur OR2-3).
  115. Futterweit W: Clinical evaluation of androgen excess, In Androgen Excess Disorders in Women, Eds: Azziz R, Nestler JE, Dewailly D, Lippincott-Raven Publ, Philadelphia, pp 625-633,1997.
  116. Futterweit W: Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 27:209-226, 1998.
  117. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Dunaif A: Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:1976-1987, 1998.
  118. Futterweit W: Overview of Therapy of PCOS. Abstract. International Conference on the Polycystic Ovary Syndrome, Astir Palace Hotel, Athens, Greece, November 14-17, 1998. (Chaired SessionVIII, Therapy PCOS, Nov 17,1998).
  119. Futterweit W: Polycystic ovary syndrome: clinical perspectives and management. Obst Gynecol Survey 54:403-413, 1999.
  120. Bledsoe MB, Futterweit W, Goldzieher JW, Goodman NF, Petak SM, Smith KD, Steinberger E: AACE Medical Guidelines for Clinical Practice for Management of Menopause. Chairman: Cobin RH. Endocrine Practice 5:355-366, 1999.
  121. Tucci S, Futterweit W, Gabrilove JL, Conception ES, Greenberg DA, Villanueva R, Davies TF. The insulin receptor gene region contains a gene for polycystic ovary syndrome (PCOS). Abstract, 82nd Meeting of the Endocrine Society, Toronto, Canada, June 21-24, 2000.
  122. Tucci S, Futterweit W, Concepcion ER, Greenberg DA, Villanueva R, Davies TF, Tomer Y. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 86:446-449, 2001.
  123. Research in Medicine 2000, Mount Sinai School of Medicine, October 24, 2001. Tucci S, Futterweit W, Concepcion ER, Greenberg DA, Villanueva R, Davies TF, Tomer Y. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. Mt. Sinai J Med 68:127, 2001.
  124. Bloomgarden ZT, Futterweit W, Poretsky L. Use of insulin sensitizing agents in patients with polycystic ovary syndrome. Endocrine Practice 7:279-286, 2001.
  125. Goodman NF, Bledsoe MB, Cobin RH, Futterweit W, Goldzieher JW, Petak SM, Smith KD, Steinberger E. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders. Endocrine Practice 7:120-134, 2001.
  126. Futterweit W, Dronova L, Tomer Y, Siegel S. Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fert Steril. 77:855-858, 2002.
  127. Futterweit W. Women & Diabetes. Polycystic Ovary Syndrome. Diabetes Self-Management. Nov/Dec 56-59, 2001.
  128. Futterweit W, Legro RS. Management Options in PCOS for the Endocrinologist. AACE 2002 Syllabus, 11th Annual Meeting of AACE, Chicago, IL, May 1-5, 2002. pp 131-136.
  129. Siegel, S, Futterweit W, Davies TF, Concepcion,ES, Greenberg, DA., Villanueva R, Tomer Y. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril 78:1240-1243,2002.
  130. Miller WL, Nestler JE, Futterweit W. Viewpoints on PCOS. Endocrine News 2004;29:13-19.
  131. Kinkhabwala S, Schiano TD, Futterweit W, Gambarin-Gelwan M, Bodian C, Yeh HC. Prevalence of non-alcoholic fatty liver disease in polycystic ovary syndrome. Program of the 87th Annual Meeting of the Endocrine Society, San Diego, CA, June 5th, 2005, p. 445 (Abstract P2-365).
  132. Kinkhabwala S, Futterweit W. Non-alcoholic fatty liver disease in lean, overweight, and obese women with polycystic ovary syndrome. Abstract. Androgen Excess Society, Third Annual Meeting. San Diego, CA, June 3, 2005
  133. American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. Polycystic Ovary Writing Committee. Cobin RH, Futterweit W, Nestler JE, Reaven GM, Jellinger PS, Handelsman Y, Redmond GP, Thatcher SS. Endocrine Practice 2005;11:125-134.
  134. Futterweit W. PCOS and Insulin Resistance: Synthesis and Implications for Clinical Practice. AACE 2005 PCOS Conference: PCOS and the Metabolic Syndrome. Hyatt Regency, Washington, DC, September 12, 2005.
  135. Maher JF, Hines RS, Futterweit W, Crawford S, Lu D, Shen P, Oefner P, Kazi M, Wilson JG, Subauste JS, Cowan BD. FEMIA is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol 2005;21:330-335.
  136. Futterweit, W. Non-alcoholic Fatty Liver Disease (NAFLD) in PCOS. Invited Lecture at the International PCOS Conference, Athens, Greece, March 2006.
  137. AACE Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause. AACEMenopause Guidelines Revision Task Force. Cobin, RH, Futterweit W, Ginzburg SB, Goodman NF, Kleerekoper, M, Licata AA, Meikle AW, Petak SM, Porte KL, Sellin RV, Smith KD, Verso MA, Watta MB. Endocrine Practice, 2006;12:315-337.
  138. Futterweit W, Diamanti-Kandarakis E, Azziz R. Clinical features of polycystic ovary syndrome, In: Azziz R, Nestler JE, Dewailly D, eds. Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders, Second Ed. , New Jersey, Humana Press Inc., Totowa, NJ, pp 155-167,2006.
  139. Futterweit W, Schiano T, Yeh H-C, Gambarin-Gelwan M. Re: Steatohepatitis and fatty liver in women with PCOS. Eletter; J Clin Endocrinol Metab; 7 July 2006.
  140. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. Position Statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-4245.
  141. Futterweit W, Goodman N, Rodriguez-Rigau L, Nader S. Evaluation of hyperandrogenism and polycystic ovary syndrome. 2006-2007;AACE Self-Assessment Program (ASAP).
  142. Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007;5:496-501.
  143. Futterweit W, Schiano T, Yeh HC, Gambarin-Gelwan M. (Letter). Steatohepatitis and fatty liver in women with PCOS. (Publ. in internet JCEM Letters, 2006.)
  144. Yeh, H-C, Futterweit W. Hyperechoic ovarian stroma: Not an ultrasonographic sign of polycystic ovarian syndrome. American Institute of Ultrasound in Medicine, March 15-18, 2007. Speaker Dr. Yeh, Section Gynecology: The Ovary.
  145. Cheang KI, Nestler JE, Futterweit W. Risk of coronary artery disease in mothers of women with PCOS. Abstract (P3-282). Presented at the 89th Annual Meeting of the Endocrine Society, Toronto, Canada, June 4, 2007.
  146. Patel AA, Bloomgarden ZT, Futterweit W. Low-grade albuminuria in women with polycystic ovarian syndrome. Abstract (P4-196). Presented at the 89th Annual Meeting of the Endocrine Society, Toronto, Canada, June 5, 2007.
  147. Yeh HC, Futterweit W. Hyperechoic Ovarian Stroma: Not an ultrasonographic sign of polycystic ovary disease. Presented at 93rd Meeting of Radiological Society North America, , Chicago, Ill., Nov 25-30,2007.
  148. Futterweit W. Nonalcoholic fatty liver disease in polycystic ovary syndrome, In: Diamanti-Kandarakis E, Nestler JE, Panidis D, Pasquali R, eds. Insulin Resistance and Polycystic Ovary Syndrome: Pathogenesis, Evaluation and Treatment. Humana Press Inc., Totowa, New Jersey, pp 303-315, 2007.
  149. Magnotti M, Futterweit W. Obesity and the polycystic ovary syndrome. Med Clin North Am. 2007;91:1156-68.
  150. Futterweit W, Rodriguez-Rigau L, Goodman G, Nadar S. ASAP AACE. Evaluation of hyperandrogenism and polycystic ovary syndrome., 2007
  151. Wilkins, Endocr Pract 2007;34:761-789.
  152. Patel AA, Bloomgarden ZT, Futterweit W. Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract 2008;14:193-200.
  153. Patel AA, Bloomgarden ZT, Futterweit W. Letter to Editor: Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract 2008;14:649.
  154. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarikis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchell ; (Task Force on the Phenotype of the Polycystic Ovary Syndrome of the Androgen Excess and PCOS Society). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-88.
  155. Cheang KI, Nestler JE, Futterweit W. Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. Endocr Pract. 2008;14:1084-94
  156. Bishop SC, Basch S, Futterweit W. Polycystic Ovary Syndrome : Depression, and Affective Disorders. Endocr Pract 2009;15:475-82
  157. Azziz R, Carmina E, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Wichell SF. Reply of the Authors. The Androgen Excess and PCOS Society. Fertil Steril 2009 (May 28) (Epub ahead of print)
  158. Wild, RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic D. Assessment of Cardiovascular risk and Prevention of Cardiovascular disease in women with the polycystic ovary syndrome: A position statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038-49.
  159. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Obst Gynecol 2011;17:45-72
  160. Futterweit W, Goodman N, Rodriguez-Rigau L. Evaluation of Hyperandrogenism and Polycystic Ovary Syndrome. ASAP 2011;117:145-52.
  161. Futterweit W, Goodman N, Rodriguez-Rigau L. Evaluation and Treatment of Hyperandrogenism and Polycystic Ovary Syndrome. ASAP American College of Endocrinology (ACE) Self Assessment Program (online). Available at http://asap.aace.com 2011;117:1-28.
  162. Carmina E, Futterweit W, Kingsley P, Unger R: Symposium – Hair Loss in Women. Mt Sinai School of Medicine, May 19, 2011. Sponsored for the public by the AE-PCOS Society.
  163. American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. Polycystic Ovary Syndrome Writing Committee: RH Cobin (Chair), W Futterweit, JE Nestler, GM Reaven, PS Jellinger, Y Handelsman, GP Redmond, SS Thatcher. ASAP American College of Endocrinology (ACE) Self Assessment Program (online). Available at http://asap.aace.com 2011 (from 2005).
  164. Futterweit W. Androgenic Alopecia in Women: Diagnosis and Pathogenesis. Reproductive Endocrine Corner; The First Messenger, Aug-Sept 2011; pgs 8 and 19.
  165. Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2012;97:225-230
  166. Witchel SF, Recabarren SE, González F, Diamanti-Kandarakis E, Cheang KI, Duleba AJ, Legro RS, Homburg R, Pasquali R, Lobo RA, Zouboulis CC, Kelestimur F, Fruzzetti F, Futterweit W, Norman RJ, Abbott DH. Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.2012. Endocrine 2012;42:526-534
  167. Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin. Messer C, Boston R, Leroith D, Geer E, Miller JD, Messer M, Futterweit W Endocr Pract. 2012 Sep-Oct;18(5):685-93.
  168. Futterweit W. Nonalcoholic fatty liver disease in polycystic ovary syndrome. In: Reproductive Medicine Corner. AACE First Messenger. Vol. 22 No 23, June/July 2013; page 30.
  169. American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders. Goodman NF, Bledsoe MB, Cobin RH, Futterweit W, Goldzieher JW, Petak SM, Smith KD, Steinberger E; American Association of Clinical Endocrinologists Hyperandrogenic Disorders Task Force. Endocr Pract. 2001 Mar-Apr;7(2):120-34. Review.
  170. Cramina E, Futterweit W, Cobin R. et al. American College of Endocrinology, AACE, AE-PCOS Society. Clinical Review of PCOS. In Print in Endocrine Review, 2015.
  171. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. Endocr Pract. 2015 Nov;21(11):1291-300. doi:10.4158/EP15748.DSC. PMID: 26509855
  172. Dr.Futterweit, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. Endocr Pract. 2015 Dec;21(12):1415-1426. PMID: 26642102
  173. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Futterweit W, Goodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR; AACE Reproductive Endocrinology Scientific Committee. Endocr Pract. 2015 Sep;21(9):1066-73. doi: 10.4158/EP14434.PS.